Form 4: Actinium Pharmaceuticals CFO Cancels Stock Options
SEC Form 4
Chief Financial Officer Steve O'Loughlin cancels multiple stock options at Actinium Pharmaceuticals effective March 31, 2025.
Summary
- Steve O'Loughlin, the Chief Financial Officer of Actinium Pharmaceuticals, has cancelled several stock options.
- The cancellation was effective March 31, 2025.
- The stock options were cancelled in exchange for nominal consideration, according to an Option Cancellation and Release Agreement.
- The cancelled options had various exercise prices and expiration dates, ranging from October 1, 2025, to December 28, 2033.
- The cancelled options covered a significant number of common stock shares.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing regarding stock option cancellations, with no inherent positive or negative sentiment.
Industry Context
Executive compensation adjustments are common in the pharmaceutical industry, often tied to performance or strategic shifts.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Effective date of stock option cancellation. |
| 04/02/2025 | Date of signature on the Form 4 filing. |
| 10/01/2025 | Expiration date of one of the cancelled stock options. |
| 04/14/2026 | Expiration date of one of the cancelled stock options. |
| 03/14/2027 | Expiration date of one of the cancelled stock options. |
| 07/13/2028 | Expiration date of one of the cancelled stock options. |
| 07/12/2029 | Expiration date of one of the cancelled stock options. |
| 08/12/2030 | Expiration date of one of the cancelled stock options. |
| 09/01/2031 | Expiration date of one of the cancelled stock options. |
| 07/01/2032 | Expiration date of one of the cancelled stock options. |
| 12/28/2033 | Expiration date of one of the cancelled stock options. |
Keywords
stock options, cancellation, Actinium Pharmaceuticals, CFO, Steve O'Loughlin, ATNM, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.